Kenya Receives First 21,000 Long-Acting HIV Prevention Doses
Kenya has received its first 21,000 doses of Lenacapavir, a long-acting injectable HIV prevention drug. This milestone offers a more convenient, twice-yearly option for at-risk populations, strengthening the country’s fight…
Read more